Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism

Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism

IntroductionChronic heart failure (CHF) has become an increasing concern with the aging of the population. This study aims to evaluate the effectiveness and safety of Qili Qiangxin capsules (QLQX) for CHF.MethodsA systematic review and meta-analysis on clinical studies was conducted. The mechanisms...

Full description

Bibliographic Details
Main Authors: Xiaoxiao Xing, Jianbo Guo, Juefei Mo, Huashan Li, Hui Zhang, Baoyi Shao, Yifan Wang, Haidi Li, Jianan Wang, Cheuk Lung Leung, Yun Jiang, Weixian Yin, Haiyong Chen, Qingyong He
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
chronic heart failure
Qili Qiangxin
systematic review
myocardial apoptosis
adjuvant efficacy
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1090616/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1090616/full

Similar Items